What is OptimizeRx's repayments of long-term debt?

OptimizeRx (OPRX) reported repayments of long-term debt of $2.69M in Q1 2026.

How has OptimizeRx's repayments of long-term debt changed year-over-year?

OptimizeRx's repayments of long-term debt increased by 438.2% year-over-year, from $500K to $2.69M.

What is the long-term trend for OptimizeRx's repayments of long-term debt?

Over 2 years (2023 to 2025), OptimizeRx's repayments of long-term debt has grown at a 116.3% compound annual growth rate (CAGR), from $1.71M to $8M.

OptimizeRx OPRX Repayments of Long-Term Debt

Repayments of Long-Term Debt at other companies

TFS FinancialTFSL

$25.4M-74.7%

ConstelliumCSTM

$1M0.0%

Franklin CoveyFC

$0-100%

TFX

TeleflexTFX

$25.25M-48.6%

RDI

Reading International, Inc.RDI

$2.25M-86.7%

QuidelOrtho CorporationQDEL

$22.4M-37.8%

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's repayments of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's repayments of long-term debt?: OptimizeRx (OPRX) reported repayments of long-term debt of $2.69M in Q1 2026.
How has OptimizeRx's repayments of long-term debt changed year-over-year?: OptimizeRx's repayments of long-term debt increased by 438.2% year-over-year, from $500K to $2.69M.
What is the long-term trend for OptimizeRx's repayments of long-term debt?: Over 2 years (2023 to 2025), OptimizeRx's repayments of long-term debt has grown at a 116.3% compound annual growth rate (CAGR), from $1.71M to $8M.